Physician profile
Jarea Small
NPI 1346023280
$4,288.99
in general payments reported to CMS, 2019-2025
20 companies · $2,605 in 2025
The $2,605 reported for 2025 was more than what 96% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,684 · 2025: $2,605.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,288.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,371.41 | 2024-2025 | |
| Madrigal Pharmaceuticals | $473.35 | 2024-2025 | Rezdiffra, Resmetirom |
| Ardelyx, INC. | $375.72 | 2024-2025 | Ibsrela |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $375.57 | 2024-2025 | Xifaxan |
| Phathom Pharmaceuticals, INC. | $282.94 | 2024-2025 | Voquezna |
| Janssen Biotech, INC. | $198.26 | 2025 | Tremfya, Simponi, Stelara |
| Thd America, INC. | $180.00 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $172.24 | 2024-2025 | Dupixent |
| Lilly USA, LLC | $158.40 | 2024-2025 | Omvoh |
| Pfizer INC. | $123.88 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $117.06 | 2025 | Entyvio |
| Ipsen Biopharmaceuticals, INC | $114.82 | 2024-2025 | Iqirvo |
| Genzyme Corporation | $111.62 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $64.65 | 2024 | Dificid |
| Braintree Laboratories, INC. | $57.24 | 2025 | Suflave, Sutab |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $27.73 | 2024 | Injectafer |
| Exact Sciences Corporation | $26.99 | 2024 | Cologuard Collection Kit |
| Aimmune Therapeutics, INC. | $24.10 | 2025 | Zenpep |
| Redhill Biopharma INC. | $16.61 | 2024 | Talicia |
| Celgene Corporation | $16.40 | 2024 | Zeposia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jarea Small listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.